Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
211M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
57.5M
-
Shares change
-
+1.02M
-
Total reported value, excl. options
-
$834M
-
Value change
-
+$19.1M
-
Put/Call ratio
-
0.33
-
Number of buys
-
46
-
Number of sells
-
-44
-
Price
-
$14.52
Significant Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) as of Q3 2016
120 filings reported holding INSM - INSMED Inc - Common Stock, par value $0.01 per share as of Q3 2016.
INSMED Inc - Common Stock, par value $0.01 per share (INSM) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.5M shares
of 211M outstanding shares and own 27.25% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (10M shares), FMR LLC (9.28M shares), ORBIMED ADVISORS LLC (5.25M shares), Palo Alto Investors, LLC (5.09M shares), VANGUARD GROUP INC (3.48M shares), JANUS CAPITAL MANAGEMENT LLC (2.88M shares), BlackRock Fund Advisors (2.39M shares), JPMORGAN CHASE & CO (1.6M shares), BlackRock Institutional Trust Company, N.A. (1.55M shares), and STATE STREET CORP (1.41M shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.